Indication
Hepatocellular Carcinoma AJCC v7
2 clinical trials
4 products
1 drug
Clinical trial
A Phase II Study of Pembrolizumab (MK-3475) in Hepatitis C Virus Positive and Negative Subjects With Advanced Hepatocellular Carcinoma Who Progressed on or Were Intolerant to First-Line Systemic TherapyStatus: Completed, Estimated PCD: 2023-08-09
Product
Elbasvir/GrazoprevirProduct
PembrolizumabProduct
RibavirinClinical trial
A Phase Ib Study of Guadecitabine (SGI-110) and Durvalumab (MEDI 4736) in Patients With Advanced Hepatocellular Carcinoma, Pancreatic Adenocarcinoma, and Cholangiocarcinoma/Gallbladder CancerStatus: Active (not recruiting), Estimated PCD: 2021-03-02
Drug
AN0025Product
Guadecitabine